Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in France

por Gaugain, Loïg, Cawston, Hélène, Dubois de Gennes, Coline, Sanchez Alvares, Javier, Nahon, Pierre, Mazaleyrat, Benjamin, Le Dissez, Clément
Publicado 2023